SNY
$54.46
Revenue | $7631Mn |
Net Profits | $499Mn |
Net Profit Margins | 6.54% |
Sanofi’s revenue fell -66.65% since last year same period to $7631Mn in the Q4 2024. On a quarterly growth basis, Sanofi has generated -46.1% fall in its revenue since last 3-months.
Sanofi’s net profit jumped 189.91% since last year same period to $499Mn in the Q4 2024. On a quarterly growth basis, Sanofi has generated -82.27% fall in its net profits since last 3-months.
Sanofi’s net profit margin jumped 369.61% since last year same period to 6.54% in the Q4 2024. On a quarterly growth basis, Sanofi has generated -67.11% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.74 |
EPS Estimate Current Year | 0.74 |
Sanofi’s earning per share (EPS) estimates for the current quarter stand at 0.74 - a -46.63% fall from last quarter’s estimates.
Sanofi’s earning per share (EPS) estimates for the current year stand at 0.74.
Earning Per Share (EPS) | 0.68 |
Sanofi’s earning per share (EPS) fell -23.34% since last year same period to 0.68 in the Q4 2024. This indicates that the Sanofi has generated -23.34% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-09-30 | 1.38 | 1.57 | 13.55% |
2024-06-30 | 0.86 | 0.93 | 8.14% |
2025-01-30 | 0.74 | 0.68 | -7.53% |
2024-03-31 | 0.94 | 0.97 | 3.19% |